导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.15% | 887/4773 |
| 近一周 | -0.84% | 1329/5465 |
| 近一月 | -6.24% | 4105/5421 |
| 近一季 | -8.64% | 3357/5231 |
| 近半年 | 7.32% | 702/4920 |
| 近一年 | 9.06% | 1242/4394 |
| 近两年 | 112.26% | 504/2954 |
| 近三年 | 66.72% | 387/2253 |
| 成立以来 | 25.44% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.65% 4172/4961 |
41.61% 743/5312 |
- - |
- - |
| 2025 | 35.67% 977/4813 |
0.84% 1757/3635 |
0.78% 2566/4076 |
40.60% 747/4524 |
-5.05% 3507/4813 |
| 2024 | 15.80% 881/3463 |
-5.45% 1902/2808 |
-3.33% 1348/3014 |
16.29% 1487/3129 |
8.95% 358/3463 |
| 2023 | 6.53% 166/2656 |
28.45% 80/2280 |
-1.92% 541/2385 |
-11.87% 2094/2515 |
-4.05% 854/2655 |
| 2022 | -32.71% 1683/2207 |
-24.22% 1760/1919 |
0.64% 1535/2016 |
-17.29% 1577/2113 |
6.66% 353/2208 |
| 2021 | 2.91% 625/1822 |
-9.55% 1109/1255 |
16.89% 192/1330 |
-9.22% 1170/1466 |
7.23% 191/1822 |
| 2020 | 47.28% 198/1250 |
1.93% 139/1028 |
31.44% 40/1067 |
3.62% 974/1164 |
6.09% 766/1184 |
| 2019 | 54.21% 76/1092 |
32.13% 180/754 |
-4.40% 428/804 |
10.97% 40/850 |
10.02% 172/918 |
| 2018 | -30.19% 464/834 |
- - |
- - |
- - |
-12.97% 497/691 |
| 2017 | 6.61% 332/714 |
- - |
- - |
- - |
- - |
| 2016 | -24.52% 473/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 鹏华中证移动互联网指数(LOF)A VS. 长安沪深300非周期A(740101) |